Ginkgo Bioworks Holdings, Inc. · Biotech

DNA

Elevated riskNext report: Around Nov 5 (est.)

View price ↗

The short version

A company still losing money with shrinking sales, with elevated risk. Institutions are adding.

Watch out for

About 12 months of cash left at its current burn
Losing money
Share count growing 9.7% a year

Money moves

Insiders sold $1.3M in the last 30 days
Institutions added 12% to their holdings in the quarter ending June 2026 (98 bought, 57 sold)

Facts from SEC filings, not a recommendation.

What the price means

Price as of Oct 26

$9.990.0% that day

Company value: $636M; Share price times all shares
Price vs sales: 5.7x; No profit over the last year, so this compares value with sales instead
Cash vs value: 13%; Cash as a share of company value

From DNA's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.

The business over time

Last 12 quarters, from SEC filings

Sales, Jun '26

$20.2M-48% vs a year earlier

Sep '23Tap a barJun '26

Last 12 months: $111.9M, down 47% from the 12 months before. Over 5 years, sales grew about 17% a year.

What the price assumes

Your guesses, our math

Move the sliders to your own view of DNA. Starting points are the company's recent numbers.

Sales growth-10% a yearRecently: -47% a yearProfit margin19%Last 12 months: 19.4%P/E at the end15xMany steady companies trade at 12x to 25xShare count change+10% a yearBelow zero means buybacks; above zero means new shares (dilution)

Sales in 5 years$66M

Profit in 5 years$13M

Price these guesses point to$1.83-82% vs $9.99 todayAbout -29% a year, before dividends

What today's price needs: with a 19% margin and a 15x P/E, sales would have to grow about 26% a year for 5 years just to match today's price.

Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.

Price

Price chart by TradingView.

Business quality

The checklist Warren Buffett-style investors use. Annual numbers for 2025.

0/5Weak

MissReturn on equity 15%+Earns a lot on the money owners have in the business.-0.1%
MissNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.-0.2%
MissProfitable every yearSteady profits, not one good year.0 of 7 years
MissFree cash flow positiveBrings in more cash than it spends to run and grow.-$178.7M
MissShare count not growingNot diluting owners. Falling means buybacks.+32.1% in 3 years

Revenue: $170.2M; -25.1% vs prior year
5-year growth: +17.3%/yr; revenue, per year
Current ratio: 4.92x; short-term assets / bills due
Free cash flow: -$178.7M; -105.0% of revenue

From annual reports filed with the SEC. Not in this company's SEC data, so not scored: debt under half of equity, gross margin 40%+. A checklist is a starting point for research, not a verdict.

Latest quarter

Quarter ended Jun 30, 2026

Reported Aug 5

Revenue: $20.2M; -48.5% YoY
EPS: -$0.75; vs -$1.10
Op. margin: -290.5%; -141.9 pts
Gross margin: 91.5%; +5.2 pts
Free cash flow: -$46.9M

Insider rating

Last 90 days

24Selling

4 insiders sold $1.3M (not pre-planned)

50 is neutral. Buying by more insiders, top executives and bigger stakes raises it. Selling lowers it; pre-planned sales count less.

Weekly insider trend

13 weeks agoBoughtSoldThis week

Filing buzz

Last 7 days vs normal

71/ 100

This week: 4
Normal week: 1.7
vs normal: 2.4x

SEC filings of any kind. 50 means a normal week.

Institutional ownership

Accumulating+12.0%

Institutions added 12.0% to their holdings. 98 bought, 57 sold.

Shares held by institutions36.2M

Sep '24Jun '26

Safety check

From SEC filings

Share count growthYearly rate, last 3 years

+9.2%

Cash runwayAt last year's cash burn

6 months

Debt to equityLatest balance sheet: debt compared with what owners have

Total liabilities $569.8M

Shares outstandingLatest reported

64M

Why elevated risk

Losing money, losses are large next to sales
About 6 months of cash left at its current burn
Share count growing 9.2% a year
Revenue down 25.1% from the year before

Earnings reports

Last 12

Next reportAround Nov 5 (est.)Estimated from the same quarter last year

Results filedAug 5
Results filedMay 7
Results filedFeb 26
Results filedNov 6, 2025
Results filedAug 7, 2025

Flags and big holders

Offerings 6 months, flags 12 months, holders 90 days

5%+ holder update (passive)Jul 30 · View filing ↗Big holder

Insider trades

Open-market buys and sells, last 90 days

Bought$00 insiders

Sold$1.3M4 insiders, 0 pre-planned

Insider	Trade	Shares	Avg price	Value	Owns after	Date
Steven P. CoenSee remarks	Sell	766	$10.14	$8K	50K	Oct 19Filing ↗
-1.5% of their holdings Not a pre-planned sale Filed 2 days after
Barry Canton10% owner	Sell	41K	$10.14	$418K	454K	Oct 19Filing ↗
-8.3% of their holdings 2 trades Held via Spouse Not a pre-planned sale Filed 2 days after
Reshma P. ShettySee remarks	Sell	41K	$10.14	$418K	356K	Oct 19Filing ↗
-10.4% of their holdings 2 trades Held via Spouse Not a pre-planned sale Also Director and 10% owner Filed 2 days after
Jason R KellySee remarks	Sell	46K	$10.14	$463K	129K	Oct 19Filing ↗
-26.1% of their holdings Not a pre-planned sale Also Director Filed 2 days after
Steven P. CoenSee remarks	Sell	2K	$15.00	$36K	49K	Oct 5Filing ↗
-4.6% of their holdings Not a pre-planned sale Filed 2 days after